CompoAtlas

Melatonin 5 mg

Natural health product licensed in Canada

Other names
Melatonin
Licence holder
Vitanergy Health Inc.
NPN or DIN-HM
80120449
Status
Active licence
Licence date
8 August 2022
Revision date
16 July 2026
Form
Comprimé
Route of administration
Sublinguale
Application type
Officinale

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
N-Acétyl-5-méthoxytryptamine

Source : Mélatonine

5 mg

Non-medicinal ingredients

Lactose monohydraté, Croscarmellose de sodium, Feuille de menthe poivrée, Cellulose microcristalline, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 yearsminimum: 1 Comprimé ; maximum: 2 Comprimé1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule (e.g. shift-work and jet lag). Helps re-set the body's sleep-wake cycle (aspect of the circadian rhythm) and increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule (e.g. shift work and jet lag). Helps re-set the body's sleep-wake cycle (aspect of the circadian rhythm) and prevent and/or reduce the effects of jet lag/minimize jet lag (e.g. daytime fatigue, sleep disturbance) (for people travelling by plane easterly across two or more time zones/if flying east over two or more time zones). Helps to prevent and/or reduce the effects of jet lag/minimize jet lag (e.g. daytime fatigue, sleep disturbance) (for people travelling by plane easterly across two or more time zones/if flying east over two or more time zones). Helps to re-set the body's sleep-wake cycle (aspect of the circadian rhythm). Helps to speed up/reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people who fall asleep slowly/with delayed sleep phase disorder.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80120449

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line